Table 1. 1BASELINE DEMOGRAPHICS.
Rivaroxaban (n = 7 081) | Warfarin (n = 7 090) | |
CHADS2 score (mean) | 3.48 | 3.46 |
2 (%) | 13 | 13 |
3 (%) | 43 | 44 |
4 (%) | 29 | 28 |
5 (%) | 13 | 12 |
6 (%) | 2 | 2 |
Prior VKA use (%) | 62 | 63 |
Congestive heart failure | 63 | 62 |
Hypertension (%) | 90 | 91 |
Diabetes mellitus (%) | 40 | 39 |
Prior stroke/TIA/embolism (%) | 55 | 55 |
Prior myocardial infarction (%) | 17 | 18 |
Based on intention-to-treat population